Healthcare marketing has long relied on medical claims data to find the right patients and providers. dentsu and BranchLab think they can do better—with fewer privacy tradeoffs.
The global media and marketing giant announced a strategic partnership with BranchLab, an AI-native startup focused on privacy-conscious audience modeling. The goal: help healthcare brands identify and reach consumers, caregivers, and healthcare professionals using deep learning models trained on anonymized clinical data—rather than traditional claims-based targeting alone.
If it works as promised, the partnership could signal a broader shift in how healthcare audiences are built in a post-cookie, privacy-regulated world.
Moving Beyond Claims-Based Targeting
For years, healthcare marketers have leaned heavily on medical claims data to infer patient conditions and target ads accordingly. While effective, that approach can be expensive, slow to refresh, and increasingly scrutinized under evolving privacy laws.
BranchLab’s Pathwai™ platform takes a different route. Instead of activating claims data directly, it trains brand-specific neural networks on anonymized health outcomes—such as diagnoses, prescription fills, procedures, and patient care events. The system then predicts likely target audiences within standard demographic datasets.
In this new partnership, dentsu integrates its proprietary consumer data with Pathwai’s modeling engine. The result, the companies say, is healthcare-relevant, targetable audience segments built from dentsu’s existing data—segments anticipated to perform as well as or better than legacy claims-based approaches.
That’s a bold claim in a market where ROI is closely tracked and incremental prescription lift can make or break campaigns.
How Pathwai Works
At the core of the collaboration is Pathwai, a neural network-based modeling system built specifically for healthcare marketing. The platform uses deep learning to translate millions of anonymized patient journeys into predictive patterns.
Instead of handing marketers static audience lists, Pathwai offers what BranchLab describes as an “agentic” self-serve interface. In practical terms, that means dentsu teams can design, activate, and measure healthcare audiences in-house—without relying solely on third-party data brokers.
The system continuously refines its models using supervised AI learning informed by real-world health outcomes. As campaigns run and new anonymized data flows in, the models adapt, ideally improving precision over time.
Audience segments can then be activated across major media channels, including streaming and addressable TV, programmatic display, social, and other digital formats.
For healthcare brands increasingly investing in omnichannel strategies, cross-channel activation is table stakes.
Privacy as a Selling Point
Privacy is central to the pitch.
The companies emphasize that the data used for modeling is HIPAA de-identified and designed to support compliance with state privacy regulations. That positioning matters as regulators scrutinize how health-related data is used in advertising, particularly in light of recent FTC enforcement actions and state-level privacy laws like California’s CCPA/CPRA.
By modeling condition likelihoods within demographic datasets—rather than targeting individuals based directly on identifiable health records—the partnership aims to offer what it calls a “privacy-conscious” alternative.
Brad Fox, SVP of Health Media at dentsu, framed the deal as a way to connect “real-world health outcomes with dentsu’s privacy-conscious consumer intelligence,” while bringing audience design in-house.
Michael Parkes, BranchLab’s Co-Founder and CRO, described the integration as an “outcome-driven” approach anticipated to deliver measurable gains in audience quality, incremental prescriptions, and new healthcare consumer engagement.
The emphasis on measurable outcomes reflects a broader shift in healthcare marketing, where performance metrics increasingly outweigh reach alone.
Why This Matters Now
The timing is notable.
Healthcare marketers are navigating a convergence of pressures: tightening privacy regulations, signal loss from third-party cookies, rising media fragmentation, and growing demand for proof of ROI from brand teams and finance departments alike.
At the same time, AI has become the industry’s go-to lever for extracting more value from first-party and proprietary datasets.
Large agency networks like dentsu are racing to differentiate their data stacks. Owning—or at least tightly integrating—advanced AI modeling capabilities can help them compete with rival holding companies and specialized healthcare agencies that tout proprietary health intelligence platforms.
For BranchLab, the partnership provides scale. By plugging into dentsu’s global media infrastructure and consumer datasets, the company gains a pathway to nationwide activation across major healthcare brands.
Key Benefits for Healthcare Marketers
According to the companies, the partnership delivers several advantages:
- Unlocking new value from dentsu’s consumer data by transforming it into healthcare-relevant segments
- Predictive targeting powered by neural networks trained on anonymized health outcomes
- Continuous supervised AI learning to improve performance over time
- HIPAA-de-identified modeling designed for nationwide, privacy-conscious activation
The integration also allows brand first-party data to be incorporated into the modeling process, potentially improving match rates and qualified reach.
In an industry where incremental prescription growth and patient acquisition are tightly measured, even modest gains in targeting efficiency can translate into significant revenue impact.
A Broader Industry Signal
This collaboration reflects a larger trend: the blending of advanced AI modeling with privacy-forward data strategies.
Rather than relying solely on legacy health data brokers or deterministic claims matching, agencies and brands are experimenting with probabilistic, AI-driven approaches that infer likely health interests from broader datasets.
Whether this model can consistently outperform traditional claims-based targeting remains to be seen. Healthcare marketers are notoriously data-driven—and skeptical.
But if dentsu and BranchLab can demonstrate measurable lift while maintaining compliance and consumer trust, the partnership could point toward a new standard in healthcare audience design.
For now, it represents another sign that AI isn’t just optimizing ad placement. It’s reshaping how audiences themselves are defined.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
